Skip to main content

Table 1 Correlations between the expression of circFAM13B and clinicopathological features in BCa patients

From: HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1/PKM2 pathway

Characteristics

Case

CircFAM13B

P value

Low

High

All cases

72

54

18

 

Age(years)

   

0.6802

  < 65

31

24

7

 

  ≥ 65

41

30

11

 

Gender

   

0.3755

  Male

50

36

14

 

  Female

22

18

4

 

Tumor stage

   

0.0131*

  pTa-pT1

23

13

10

 

  pT2-pT4

49

41

8

 

Histological grade

   

0.2482

  Low

24

16

8

 

  High

48

38

10

 

Tumor size(cm)

   

0.6681

  < 3

25

18

7

 

  ≥ 3

47

36

11

 

Lymph metastasis

   

0.5766

  No

44

32

12

 

  Yes

28

22

6

 
  1. *P < 0.05